FI73679C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara ergolinderivat och mellanprodukt foer anvaendning vid foerfarandet. - Google Patents
Foerfarande foer framstaellning av nya terapeutiskt anvaendbara ergolinderivat och mellanprodukt foer anvaendning vid foerfarandet. Download PDFInfo
- Publication number
- FI73679C FI73679C FI832789A FI832789A FI73679C FI 73679 C FI73679 C FI 73679C FI 832789 A FI832789 A FI 832789A FI 832789 A FI832789 A FI 832789A FI 73679 C FI73679 C FI 73679C
- Authority
- FI
- Finland
- Prior art keywords
- compound
- formula
- alkyl
- compounds
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH477282 | 1982-08-09 | ||
CH4772/82A CH649998A5 (de) | 1982-08-09 | 1982-08-09 | Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff. |
Publications (4)
Publication Number | Publication Date |
---|---|
FI832789A0 FI832789A0 (fi) | 1983-08-02 |
FI832789A FI832789A (fi) | 1984-02-10 |
FI73679B FI73679B (fi) | 1987-07-31 |
FI73679C true FI73679C (fi) | 1987-11-09 |
Family
ID=4282273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI832789A FI73679C (fi) | 1982-08-09 | 1983-08-02 | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara ergolinderivat och mellanprodukt foer anvaendning vid foerfarandet. |
Country Status (23)
Country | Link |
---|---|
JP (1) | JPS5948480A (xx) |
AT (1) | AT383125B (xx) |
AU (1) | AU563736B2 (xx) |
BE (1) | BE897473A (xx) |
CA (1) | CA1215972A (xx) |
CH (1) | CH649998A5 (xx) |
DE (1) | DE3327705A1 (xx) |
DK (1) | DK361983A (xx) |
ES (1) | ES8502992A1 (xx) |
FI (1) | FI73679C (xx) |
FR (1) | FR2531433B1 (xx) |
GB (1) | GB2125041B (xx) |
GR (1) | GR78923B (xx) |
HU (1) | HU187600B (xx) |
IL (1) | IL69450A (xx) |
IT (1) | IT1168961B (xx) |
MY (1) | MY8700166A (xx) |
NL (1) | NL8302776A (xx) |
NZ (1) | NZ205181A (xx) |
PH (1) | PH20385A (xx) |
PT (1) | PT77168B (xx) |
SE (1) | SE8304315L (xx) |
ZA (1) | ZA835850B (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675322A (en) * | 1984-12-10 | 1987-06-23 | Eli Lilly And Company | 1-Substituted-6-n-propyl-8β-methylthio-methylergolines |
HU193782B (en) * | 1985-06-21 | 1987-11-30 | Richter Gedeon Vegyeszet | Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof |
FR2589734B1 (fr) * | 1985-11-13 | 1988-09-02 | Roussel Uclaf | Utilisation de derives de l'ergoline a l'obtention d'un medicament a visee geriatrique |
US4798834A (en) * | 1987-08-31 | 1989-01-17 | Eli Lilly And Company | Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement |
DE3913756A1 (de) * | 1989-04-21 | 1990-10-25 | Schering Ag | 8(beta)-substituierte ergoline, verfahren zu ihrer herstellung und ihre verwendung |
DE10212564B4 (de) * | 2002-03-12 | 2007-04-19 | Neurobiotec Gmbh | 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE41533B1 (en) * | 1974-03-14 | 1980-01-30 | Sandoz Ltd | Thiomethyl ergolene derivatives |
US3901894A (en) * | 1974-06-06 | 1975-08-26 | Lilly Co Eli | 8-thiomethylergolines |
US3959288A (en) * | 1974-12-13 | 1976-05-25 | Eli Lilly And Company | 8-Oxymethylergolines and process therefor |
US4166182A (en) * | 1978-02-08 | 1979-08-28 | Eli Lilly And Company | 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds |
US4382940A (en) * | 1979-12-06 | 1983-05-10 | Farmitalia Carlo Erba S.P.A. | Ercoline derivatives and therapeutic compositions having CNS affecting activity |
-
1982
- 1982-08-09 CH CH4772/82A patent/CH649998A5/de not_active IP Right Cessation
-
1983
- 1983-08-01 DE DE19833327705 patent/DE3327705A1/de not_active Withdrawn
- 1983-08-02 FI FI832789A patent/FI73679C/fi not_active IP Right Cessation
- 1983-08-04 FR FR8313018A patent/FR2531433B1/fr not_active Expired
- 1983-08-05 BE BE1/10847A patent/BE897473A/fr not_active IP Right Cessation
- 1983-08-05 GB GB08321222A patent/GB2125041B/en not_active Expired
- 1983-08-05 NL NL8302776A patent/NL8302776A/nl not_active Application Discontinuation
- 1983-08-08 ES ES524815A patent/ES8502992A1/es not_active Expired
- 1983-08-08 JP JP58144843A patent/JPS5948480A/ja active Pending
- 1983-08-08 SE SE8304315A patent/SE8304315L/xx not_active Application Discontinuation
- 1983-08-08 PT PT77168A patent/PT77168B/pt unknown
- 1983-08-08 AT AT0286383A patent/AT383125B/de not_active IP Right Cessation
- 1983-08-08 GR GR72165A patent/GR78923B/el unknown
- 1983-08-08 DK DK361983A patent/DK361983A/da unknown
- 1983-08-08 IL IL69450A patent/IL69450A/xx unknown
- 1983-08-08 AU AU17672/83A patent/AU563736B2/en not_active Expired - Fee Related
- 1983-08-08 NZ NZ205181A patent/NZ205181A/en unknown
- 1983-08-08 CA CA000434064A patent/CA1215972A/en not_active Expired
- 1983-08-08 HU HU832798A patent/HU187600B/hu unknown
- 1983-08-09 IT IT22490/83A patent/IT1168961B/it active
- 1983-08-09 ZA ZA835850A patent/ZA835850B/xx unknown
- 1983-08-09 PH PH29378A patent/PH20385A/en unknown
-
1987
- 1987-12-30 MY MY166/87A patent/MY8700166A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL69450A (en) | 1986-10-31 |
IT1168961B (it) | 1987-05-20 |
BE897473A (fr) | 1984-02-06 |
AU563736B2 (en) | 1987-07-23 |
PT77168B (en) | 1986-03-27 |
GB8321222D0 (en) | 1983-09-07 |
AU1767283A (en) | 1984-02-16 |
IT8322490A0 (it) | 1983-08-09 |
CA1215972A (en) | 1986-12-30 |
FI832789A (fi) | 1984-02-10 |
FR2531433A1 (fr) | 1984-02-10 |
SE8304315D0 (sv) | 1983-08-08 |
GB2125041A (en) | 1984-02-29 |
ES524815A0 (es) | 1985-02-01 |
ATA286383A (de) | 1986-10-15 |
PT77168A (en) | 1983-09-01 |
DK361983D0 (da) | 1983-08-08 |
HU187600B (en) | 1986-01-28 |
PH20385A (en) | 1986-12-08 |
GB2125041B (en) | 1986-04-23 |
NL8302776A (nl) | 1984-03-01 |
CH649998A5 (de) | 1985-06-28 |
MY8700166A (en) | 1987-12-31 |
FR2531433B1 (fr) | 1985-10-18 |
SE8304315L (sv) | 1984-02-10 |
ZA835850B (en) | 1985-03-27 |
AT383125B (de) | 1987-05-25 |
DE3327705A1 (de) | 1984-02-09 |
GR78923B (xx) | 1984-10-02 |
DK361983A (da) | 1984-02-10 |
JPS5948480A (ja) | 1984-03-19 |
FI832789A0 (fi) | 1983-08-02 |
ES8502992A1 (es) | 1985-02-01 |
IL69450A0 (en) | 1983-11-30 |
NZ205181A (en) | 1986-07-11 |
FI73679B (fi) | 1987-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0760811B1 (fr) | Derives d'imidazole modulateurs du recepteur h3 de l'histamine | |
TWI837169B (zh) | 甲狀腺素受體β促效劑化合物 | |
JP2022525186A (ja) | Tead転写因子新規小分子阻害剤 | |
CA2516660C (fr) | Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament | |
CA2054091A1 (en) | Isoquinolinone derivatives | |
JP7207634B2 (ja) | P2x3及び/又はp2x2/3受容体アンタゴニスト、それを含む医薬組成物及びその使用 | |
PL128296B1 (en) | Process for preparing novel 3-/1-imidazolylalkyl/-indoles | |
EP0204349A2 (de) | Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
FR2852957A1 (fr) | Nouveaux derives d'imidazo-pyridine et leur utilisation en tant que medicament | |
EP1612204A1 (en) | Hydrazone derivative | |
WO1995026342A1 (fr) | DERIVES DE 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE, LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT | |
JPH0542435B2 (xx) | ||
CA2267154A1 (fr) | Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant | |
FR2707645A1 (fr) | Dérivés d'imidazo[1,2-a]pirazine-4-one, leur préparation et les médicaments les contenant. | |
EP4382530A1 (en) | Shp2 inhibitor, pharmaceutical composition comprising same, and application thereof | |
FI73679C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara ergolinderivat och mellanprodukt foer anvaendning vid foerfarandet. | |
JPH04217682A (ja) | イミダゾ〔1,2−c〕キナゾリン誘導体、これらの製造方法、及びそれらを含む狭心症薬 | |
CA2152401C (fr) | Association synergisante ayant un effet antagoniste des recepteurs nk1 et nk2 | |
HUT52091A (en) | Process for producing new 2,3,4-substituted imidazoles and 3,4,5-substituted 1,2,5-substituted 1,2,4-triazoles and pharmaceutical compositions comprising same | |
JPH11513376A (ja) | 選択的β▲下3▼−アドレナリン作動剤 | |
JP2007297411A (ja) | イミダゾ[1,2−a]インデノ[1,2−e]ピラジン−2−カルボン酸の誘導体、その製造およびそれを含む薬物 | |
FR2862971A1 (fr) | Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament | |
JP2005527518A (ja) | 新規なカルコン(chalcone)誘導体とその使用 | |
WO2005009993A1 (en) | Novel compounds | |
WO2001044207A2 (fr) | Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2 4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: SANDOZ AG |